FDA 483 - Brigham And Women's Hospital - September 26, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Brigham And Women's Hospital in Boston received a Form 483 for deficiencies in donor screening and testing procedures. The inspection revealed that the firm failed to test oocyte and semen donors for West Nile Virus during specific seasonal periods and lacked adequate screening forms and established procedures for donor eligibility determination. These issues indicate a significant lapse in ensuring the safety of human cells, tissues, and cellular and tissue-based products (HCT/Ps).
ID · c903229a-5f5b-450c-9feb-aa32c8d60713